CUCINOTTA, MARIAPAOLA
 Distribuzione geografica
Continente #
EU - Europa 6.629
NA - Nord America 2.199
AS - Asia 944
SA - Sud America 325
Continente sconosciuto - Info sul continente non disponibili 43
AF - Africa 42
OC - Oceania 4
Totale 10.186
Nazione #
IT - Italia 4.273
US - Stati Uniti d'America 2.125
RU - Federazione Russa 1.144
SG - Singapore 337
NL - Olanda 295
CN - Cina 284
BR - Brasile 267
IE - Irlanda 263
SE - Svezia 215
DE - Germania 118
HK - Hong Kong 87
GB - Regno Unito 67
FI - Finlandia 66
FR - Francia 63
VN - Vietnam 61
IN - India 55
PL - Polonia 39
CA - Canada 32
BD - Bangladesh 17
AR - Argentina 14
TR - Turchia 14
IQ - Iraq 13
UA - Ucraina 13
CH - Svizzera 12
CZ - Repubblica Ceca 12
ES - Italia 12
CO - Colombia 11
EC - Ecuador 10
IR - Iran 10
MX - Messico 10
BE - Belgio 9
CL - Cile 8
ZA - Sudafrica 8
CI - Costa d'Avorio 7
IL - Israele 7
JP - Giappone 7
PK - Pakistan 7
ID - Indonesia 6
KE - Kenya 6
SA - Arabia Saudita 6
JM - Giamaica 5
PH - Filippine 5
PY - Paraguay 5
TN - Tunisia 5
AL - Albania 4
AZ - Azerbaigian 4
CR - Costa Rica 4
EG - Egitto 4
HN - Honduras 4
KZ - Kazakistan 4
LT - Lituania 4
MA - Marocco 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
UZ - Uzbekistan 4
AU - Australia 3
CW - ???statistics.table.value.countryCode.CW??? 3
DK - Danimarca 3
GP - Guadalupe 3
NP - Nepal 3
PR - Porto Rico 3
RO - Romania 3
SC - Seychelles 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AT - Austria 2
BH - Bahrain 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
LB - Libano 2
LY - Libia 2
MY - Malesia 2
NI - Nicaragua 2
PE - Perù 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
AM - Armenia 1
BB - Barbados 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
DZ - Algeria 1
GA - Gabon 1
GR - Grecia 1
GT - Guatemala 1
KG - Kirghizistan 1
KI - Kiribati 1
LK - Sri Lanka 1
LU - Lussemburgo 1
NO - Norvegia 1
QA - Qatar 1
SI - Slovenia 1
SM - San Marino 1
TZ - Tanzania 1
Totale 10.146
Città #
Milan 418
Rome 357
Moscow 318
Ashburn 306
Dublin 256
Dallas 244
Chandler 215
Singapore 204
Naples 176
San Jose 144
Nyköping 136
Beijing 123
Turin 91
Hong Kong 86
Bari 75
Bologna 72
Munich 70
Palermo 67
The Dalles 63
Florence 60
Catania 51
Genoa 51
Jacksonville 51
Council Bluffs 50
Dearborn 48
Los Angeles 44
New York 42
Cambridge 34
Princeton 34
Warsaw 33
Lauterbourg 32
Medford 32
Des Moines 30
Messina 28
Trieste 27
Brescia 25
Modena 25
Cagliari 24
Hyderabad 24
Pisa 22
Turku 22
Ann Arbor 21
Lancaster 21
Parma 21
São Paulo 21
Jinan 20
Verona 20
Buffalo 18
Padova 17
Bergamo 16
Hanoi 16
Reggio Emilia 16
Ho Chi Minh City 15
Pune 15
Cascina 14
Houston 14
Nanjing 14
Atlanta 13
Boardman 13
Cosenza 13
Monza 13
Orem 13
Novara 12
Pescara 12
Prato 12
San Mateo 12
Bremen 11
Denver 11
Padua 11
Venice 11
Modugno 10
Montreal 10
Perugia 10
Udine 10
Brussels 9
Civitanova Marche 9
London 9
Lucca 9
Sassari 9
Shenyang 9
Taranto 9
Ancona 8
Helsinki 8
Ningbo 8
Redondo Beach 8
Rio de Janeiro 8
Wilmington 8
Abidjan 7
Brasília 7
Brooklyn 7
Eboli 7
Frankfurt am Main 7
Hebei 7
Johannesburg 7
Livorno 7
Oristano 7
Phoenix 7
Ravenna 7
Toronto 7
Treviglio 7
Totale 4.888
Nome #
LA LOCALIZZAZIONE ISTMICA DEL NODULO TIROIDEO MALIGNO RAPPRESENTA UN FATTORE ADDIZIONALE DI RISCHIO PER METASTASI IN PAZIENTI AFFETTI DA CARCINOMA DIFFERENZIATO DELLA TIROIDE (CDT) A BASSO RISCHIO 4.755
Oxidative Stress: Harms and Benefits for Human Health 350
ACCIDENTAL DISCOVERY OF LUNG METATSTASES FROM DIFFERENTIATED THYROID CANCER BY TC-99M PERTECHNETATE SCAN IN A PATIENT WITH SECONDARY HYPERPARATHYROIDISM 215
A didactic experiment showing the Compton scattering by means of a clinical gamma camera 215
2 years-survival analysis of patients with non-small cell lung cancer by means of 2deoxy-2-[18F]fluoro-D-glucose positron emission tomography: implications of maximum standardized uptake value (SUVmax) 211
THIONAMIDES-RELATED VASCULITIS IN AUTOIMMUNE THYROID DISORDERS: REVIEW OF CURRENT LITERATURE AND CASE REPORTS 204
99mTc-Methoxy-Isobutil-Isonitrile (MIBI) scintigraphy is an useful and cost-effective tool for assessing the risk of malignancy in thyroid nodules with indeterminate fine needle cytology (FNAC) 198
Central nervous system vasculitis after starting methimazole in a woman with Graves' disease 195
Hyperthyroidism treatment with calculated activity of 131-Radioiodine: our experience 192
Is malignant nodule topography an additional risk factor for metastatic disease in low-risk differentiated thyroid cancer? 188
Radiometabolic therapy with 131I for the ablation of the thyroid remnant in patients affected by differentiated thyroid cancer: comparison between four different activities 182
A potentially misleading finding at somatostatin receptor scintigraphy: focal pulmonary areas of intense accumulation without computed tomography-detectable lung lesions 180
Can the position of malignant thyroid nodule be considered as additional risk factor for recurrent and/or metastatic disease in patients affected by low risk differentiated thyroid cancer? 179
Follicular variant of papillary thyroid carcinoma presenting as toxic nodule in an adolescent: coexistent polymorphism of the TSHR and Gsα genes 173
Hyperthyroidism treatment with calculated activity of 131–radioiodine 165
FOLLICULAR VARIANT OF PAPILLARY THYROID CARCINOMA PRESENTING AS A TOXIC NODULE IN AN ADOLESCENT GIRL 164
Can the position of malignant thyroid nodule be considered as additional risk factor for recurrent and/or metastatic disease in patients affected by low-risk differentiated thyroid cancer? 160
Is Detection of Additional Lesions in Post-Peptide ReceptorRadionuclide Therapy Scans With Respect to DiagnosticImaging Only Due to Different Affinity of Ligands?A Report of Discordance Between Diagnostic and Posttherapy Imaging Using the Same Ligand 159
Is %ΔSUVmax a Useful Indicator of Survival in Patients with Advanced Nonsmall-Cell Lung Cancer? 153
High-grade gliomas associated with abscess: description of two rare cases and role of 99mTc-Leukoscan 150
High grade gliomas associated with abscess: description of two rare cases and role of 99mTc-Leukoscan 148
Lack of association between autonomously functioning thyroid nodules and germline polymorphisms of the thyrotropin receptor and Gαs genes in a mild to moderate iodine-deficient Caucasian population 145
Middle-Term Outcome and safety of hyperthyroid patients treated with calculated activity of radioiodine 142
IMPIEGO DEL 99mTC-MIBI PER VALUTARE IL RISCHIO DI MALIGNITA’ DEL NODULO TIROIDEO 140
Our experience with peptide receptor radionuclide therapy in patients affected by pulmonary neuroendocrine tumors 139
Peptide receptor imaging in neuroendocrine tumors: comparison between diagnostic scintigraphy and post-therapy whole-body scan 135
Middle-term outcome and safety of hyperthyroid patients treated with calculated activity of radioiodine 124
Is pre-treatment SUVmax an useful indicator of survival in patients with advanced non-small-cell lung cancer? 121
Renal function evaluation in patients undergoing repeated peptide receptor radionuclide therapy 121
Gliomas with intratumoral abscess formation: Description of new cases, review of the literature, and the role of (99m)TC-Leukoscan 119
VANTAGGI DELLA DOSIMETRIA PERSONALIZZATA VS ATTIVITA’ STANDARD DI RADIOIODIO NELLA TERAPIA DELL’IPERTIROIDISMO: LA NOSTRA ESPERIENZA 110
Two-year survival prediction in patients with stage I and II non-small cell lung cancer utilizing 18F-FDG PET/CT SUV quantification 104
Stage III-IV non small cell lung cancer: the impact of SUVmax and %SUVmax in predicting survival after chemotherapy 97
RADIOIODINE UPTAKE IN ABDOMINAL DERMOID CYST IN A PATIENT WITH DIFFERENTIATED THYROID CANCER (DTC) 84
null 42
null 27
Totale 10.186
Categoria #
all - tutte 22.875
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.875


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022209 0 0 0 0 15 1 29 8 1 49 30 76
2022/2023787 62 107 36 63 47 59 21 40 307 15 22 8
2023/20241.374 22 50 72 73 70 134 103 123 96 202 178 251
2024/20253.215 216 141 234 328 268 198 229 459 390 244 234 274
2025/20263.411 240 252 303 259 276 592 365 382 412 199 71 60
2026/2027564 115 202 97 139 11 0 0 0 0 0 0 0
Totale 10.186